Author:
Kherad Omar,Bridevaux Pierre-Olivier,Kaiser Laurent,Janssens Jean-Paul,Rutschmann Olivier T.
Abstract
Background:
There is a growing interest in better defining risk factors associated with increased susceptibility
to exacerbation in patients with COPD.
Introduction:
The aim of the study was to determine whether identification of a respiratory virus during a severe acute
exacerbation of COPD (AECOPD) increases the risk of subsequent exacerbations and mortality during a one-year followup.
Methods:
Secondary analysis of 86 COPD patients admitted for AECOPD between June 2007 and December 2008 at
Geneva’s University Hospital who were followed up for 1 year. Fifty-one percent of index AECOPD were related to viral
infection. Rate of AECOPD, time to next AECOPD, and all-cause mortality were compared between patients with vs
without viral index AECOPD.
Results:
Eighty-one cases were included in this secondary follow-up analysis. Mean exacerbation rate was 1.9 AECOPD
per person-year for patients with viral index AECOPD vs 4.0 AECOPD per person year for those with non-viral index
AECOPD. Incidence rate ratio (IRR) for subsequent AECOPD during one year follow up was lower for patients with viral
index AECOPD (IRR 0.57; [CI 95% 0.39-0.84]), after controlling for previous exacerbations, and was strongly associated
with the number of exacerbations in the year preceding the index AECOPD. During the one-year follow-up period, 16
patients (19%) died. In a Cox regression model, patients with a proven viral infection did not have a higher mortality (HR
0.56 [CI 95% 0.20 -1.58]).
Conclusion:
Viral AECOPD was not associated with a higher rate of subsequent exacerbations or mortality during the
following year.
Publisher
Bentham Science Publishers Ltd.
Subject
Pulmonary and Respiratory Medicine
Reference21 articles.
1. Vestbo J, Agusti A, Anzueto A, et al.
The Global Strategy for Diagnosis Management and Prevention of COPD (updated 2010).
Global Initiative for chronic obstructive pulmonary disease (GOLD) wwwgoldcopdcom Date last updated November 2010 Date late accessed July
2011.
2. Donaldson GC, Wedzicha JA.
COPD exacerbations 1 Epidemiology.
Thorax
2006;
61
(2)
: 164-8.
3. Agusti A, Calverley PM, Celli B, et al.
Characterisation of COPD heterogeneity in the ECLIPSE cohort.
Respir Res
2010;
11
: 122.
4. Garcia-Aymerich J, Gomez FP, Benet M etal.
Identification and prospective validation of clinically relevant chronic pulmonary disease (COPD) subtypes.
Thorax
2011;
66
(5)
: 430-7.
5. Hurst JR, Vestbo J, Anzueto A , et al.
Susceptibility to exacerbation in chronic obstructive pulmonary disease.
N Engl J Med
2010;
363
(12)
: 1128-38.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献